KEGG   DRUG: Trastuzumab and hyaluronidase
Entry
D11560            Mixture   Drug                                   
Name
Trastuzumab and hyaluronidase;
Trastuzumab and hyaluronidase-oysk;
Herceptin hylecta (TN)
Product
Component
Trastuzumab [DR:D03257], Hyaluronidase (human recombinant) [DR:D06604]
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
   DG03158  HER2 inhibitor
Remark
Product: D11560<US>
Efficacy
Antineoplastic (adjuvant)
  Disease
Breast cancer (HER2 overexpressing or ER/PR negative) [DS:H00031]
Interaction
Brite
USP drug classification [BR:br08302]
 Antineoplastics
  Monoclonal Antibody/Antibody-Drug Conjugate
   Trastuzumab/ Hyaluronidase
    D11560  Trastuzumab and hyaluronidase
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG01917  Receptor tyrosine kinase inhibitor
    DG03158  HER2 inhibitor
     D11560  Trastuzumab and hyaluronidase
Drug classes [BR:br08332]
 Antineoplastic
  DG03158  HER2 inhibitor
   D11560  Trastuzumab and hyaluronidase
Other DBs
PubChem: 384585536
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system